je.st
news
AbbVie cites tax break as motivator for Shire deal
2014-06-25 17:59:47| Biotech - Topix.net
U.S. drugmaker AbbVie says it sees a compelling tax break behind its roughly $46 billion bid to buy British counterpart Shire, and it expects the deal to expand Shire's global reach as well.
Tags: break
tax
deal
cites
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||